Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-05-26FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Radha Pharmaceuticals, Inc.)
FDA approved a generic version of hydralazine hydrochloride under an Original Application for the treatment of hypertension.
-
FDA approval · 2017-05-25FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a generic version of olmesartan medoxomil (ANDA 203281) from Glenmark Pharmaceuticals Inc., USA for the treatment of hypertensi…
-
FDA approval · 2017-05-25FDA Approved: NEBIVOLOL — Original Application (AvKARE)
FDA approved the original Abbreviated New Drug Application for Nebivolol hydrochloride from AvKARE. Nebivolol hydrochloride is indicated for…
-
FDA approval · 2017-05-23FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Original Application (Exelan Pharmaceuticals, Inc.)
The FDA approves Exelan Pharmaceuticals' lisinopril and hydrochlorothiazide tablets as an original generic product for treating hypertension…
-
FDA approval · 2017-05-15FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's original application for Amlodipine and Olmesartan Medoxomil, a generic fixed-dose combination used …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-05-05FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved the original application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc. as a generic product.
-
FDA approval · 2017-05-03FDA Approved: TELMISARTAN — Original Application (Solco Healthcare US, LLC)
The FDA approved Solco Healthcare US, LLC's original application for telmisartan, enabling a generic version of the blood pressure medicatio…
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare's generic olmesartan medoxomil tablets through an original ANDA for the treatment of hypertension.
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic combination tablet of olmesartan medoxomil and hydrochlorothiazide from Aurobindo Pharma Limited under an Original Ap…
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved an original abbreviated new drug application (ANDA) for olmesartan medoxomil, with Quallent Pharmaceuticals Health LLC as t…
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for olmesartan medoxomil as a generic treatment for hypertension.
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Ascend Laboratories, LLC)
FDA approved olmesartan medoxomil as a generic antihypertensive drug for hypertension under an Original Application to Ascend Laboratories, …
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved a generic combination tablet of olmesartan medoxomil and hydrochlorothiazide from Alembic Pharmaceuticals Inc.
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for generic olmesartan medoxomil tablets from Jubilant Cadista Pharmaceuticals Inc. to treat hypertens…
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for olmesartan medoxomil, a generic antihypertensive medication.
-
FDA approval · 2017-04-24FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Solco Healthcare US, LLC)
FDA approved the original abbreviated new drug application for a generic olmesartan medoxomil and hydrochlorothiazide combination tablet for…
-
FDA approval · 2017-04-12FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved Solco Healthcare US, LLC's supplemental application for Losartan Potassium, a generic product, enabling its continued marke…
-
FDA approval · 2017-03-30FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC. The action confirms regula…
-
FDA approval · 2017-03-30FDA Approved: CHLORTHALIDONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for chlorthalidone from Rising Pharma Holdings, Inc., a generic diuretic indicated for hypertension and…
-
FDA approval · 2017-02-27FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Cardura XL (doxazosin mesylate) from Viatris Specialty LLC.
-
FDA approval · 2017-02-24FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic fixed-dose combination of losartan potassium and hydrochlorothiazide manufactured …
-
FDA approval · 2017-02-21FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide by NorthStar Rx LLC. The approval updates the lab…
-
FDA approval · 2017-02-21FDA Approved: DOXAZOSIN — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for doxazosin from Accord Healthcare Inc. for a generic product. The approval relates to the generic…
-
FDA approval · 2017-02-21FDA Approved: DOXAZOSIN — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for doxazosin, a generic alpha-1 blocker used to treat hypertension and benign prostati…
-
FDA approval · 2017-02-21FDA Approved: DOXAZOSIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for doxazosin mesylate (doxazosin) submitted by Teva Pharmaceuticals USA, Inc.